Johnson and colleagues first discovered that MAF1 binds to the promoter of TATA-binding protein (TBP) gene at the Elk-1 binding motif in glioblastoma for inhibiting Pol II-mediated TBP transcription [59]. The gene discussed is TBP; the disease is glioblastoma.